Itﾠis anﾠangiotensin converting enzyme (ACE) inhibitorﾠused for the treatment ofﾠhypertensionﾠand some types of chronicﾠheart failure This report contains market size and forecasts of Fosinopril Sodium in global, including the following market information: Global Fosinopril Sodium Market Revenue, 2017-2022, 2023-2028, ($ millions) Global Fosinopril Sodium Market Sales, 2017-2022, 2023-2028, (Box) Global top five Fosinopril Sodium companies in 2021 (%) The global Fosinopril Sodium market was valued at US$ million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028. The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028. 10Mg Segment to Reach $ Million by 2028, with a % CAGR in next six years. The global key manufacturers of Fosinopril Sodium include Huahai Pharmaceutical, SPH, Bristol-Myers Squibb, Teva Pharmaceuticals, Viatris, ANIP Acquisition, Legistorm, Aurobindo Pharma and Chartwell Pharmaceuticals, etc. In 2021, the global top five players have a share approximately % in terms of revenue. MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Fosinopril Sodium manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks. Total Market by Segment: Global Fosinopril Sodium Market, by Dosage Strength, 2017-2022, 2023-2028 ($ Millions) & (Box) Global Fosinopril Sodium Market Segment Percentages, by Dosage Strength, 2021 (%) 10Mg 20Mg 40Mg Other Global Fosinopril Sodium Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (Box) Global Fosinopril Sodium Market Segment Percentages, by Application, 2021 (%) Hypertension Heart failure Global Fosinopril Sodium Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (Box) Global Fosinopril Sodium Market Segment Percentages, By Region and Country, 2021 (%) North America US Canada Mexico Europe Germany France U.K. Italy Russia Nordic Countries Benelux Rest of Europe Asia China Japan South Korea Southeast Asia India Rest of Asia South America Brazil Argentina Rest of South America Middle East & Africa Turkey Israel Saudi Arabia UAE Rest of Middle East & Africa Competitor Analysis The report also provides analysis of leading market participants including: Key companies Fosinopril Sodium revenues in global market, 2017-2022 (Estimated), ($ millions) Key companies Fosinopril Sodium revenues share in global market, 2021 (%) Key companies Fosinopril Sodium sales in global market, 2017-2022 (Estimated), (Box) Key companies Fosinopril Sodium sales share in global market, 2021 (%) Further, the report presents profiles of competitors in the market, key players include: Huahai Pharmaceutical SPH Bristol-Myers Squibb Teva Pharmaceuticals Viatris ANIP Acquisition Legistorm Aurobindo Pharma Chartwell Pharmaceuticals DOC Generici Cipla Menarini MS Pharma Joddes Sun Pharma
1 Introduction to Research & Analysis Reports 1.1 Fosinopril Sodium Market Definition 1.2 Market Segments 1.2.1 Market by Dosage Strength 1.2.2 Market by Application 1.3 Global Fosinopril Sodium Market Overview 1.4 Features & Benefits of This Report 1.5 Methodology & Sources of Information 1.5.1 Research Methodology 1.5.2 Research Process
